Vaccines against components of the renin-angiotensin system
Access noteAcceso Abierto
MetadataShow full item record
Even though effective drugs for treating hypertension are available, a great percentage of patients have inadequate control of their blood pressure. Unwanted side effects and inappropriate oral drug adherence are important factors that contribute to the global problem of uncontrolled hypertension. Vaccination could provide a revolutionary therapy with long-lasting effects, increasing patient compliance and therefore better control of high blood pressure. Nowadays, current immunization approaches against hypertension target renin, angiotensin I, angiotensin II, and angiotensin II type 1 receptor, key elements of the renin-angiotensin system. This article reviews the different vaccination attempts with proteins and peptides against the different molecules of the renin-angiotensin system in the last two decades, safety issues, and other novel prospects biomarkers in hypertension, and summarizes the potential of this immunomodulatory approach in clinical practice.
Cardiovascular Medicine Research Group-Tecnologico de Monterrey 0020CAT131 Agencia Nacional de Investigación y Desarrollo (ANID), Chile: FONDAP 15130011
Artículo de publicación ISI
Quote ItemHeart Fail Rev . 2020 Sep 29;1-16
The following license files are associated with this item: